585 related articles for article (PubMed ID: 25099447)
21. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
[No Abstract] [Full Text] [Related]
22. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang Y; Wiangnon S; Sripa B; Hong ST
Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
[TBL] [Abstract][Full Text] [Related]
23. Neoplasms of the liver and the bile ducts.
Choi H; Loyer EM; Charnsangavej C
Semin Roentgenol; 2004 Jul; 39(3):412-27. PubMed ID: 15372754
[No Abstract] [Full Text] [Related]
24. Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.
Harder J; Müller MJ; Fuchs M; Gumpp V; Schmitt-Graeff A; Fischer R; Frank M; Opitz O; Hasskarl J
World J Gastroenterol; 2013 Dec; 19(48):9334-42. PubMed ID: 24409060
[TBL] [Abstract][Full Text] [Related]
25. What is the incidence of biliary carcinoma in choledochal cysts, when do they develop, and how should it affect management?
Sastry AV; Abbadessa B; Wayne MG; Steele JG; Cooperman AM
World J Surg; 2015 Feb; 39(2):487-92. PubMed ID: 25322698
[TBL] [Abstract][Full Text] [Related]
26. Histological classification of liver and intrahepatic bile duct cancers in SEER registries.
Altekruse SF; Devesa SS; Dickie LA; McGlynn KA; Kleiner DE
J Registry Manag; 2011; 38(4):201-5. PubMed ID: 23270094
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of the anterior gradient protein-2 is a conserved feature during morphogenesis and carcinogenesis of the biliary tree.
Lepreux S; Bioulac-Sage P; Chevet E
Liver Int; 2011 Mar; 31(3):322-8. PubMed ID: 21281432
[TBL] [Abstract][Full Text] [Related]
29. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.
Yusuf MA; Kapoor VK; Kamel RR; Kazmi A; Uddin N; Masood N; Al-Abdulkareem A;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S36-40. PubMed ID: 20697130
[TBL] [Abstract][Full Text] [Related]
30. [Pathology of cholangiocarcinoma].
Guedj N; Bedossa P; Paradis V
Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
[TBL] [Abstract][Full Text] [Related]
31. DNA image analysis study of lesions of the gallbladder and biliary system.
Brunt EM; Kraemer BB
Liver Transpl Surg; 1996 Jul; 2(4):284-9. PubMed ID: 9346662
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
[TBL] [Abstract][Full Text] [Related]
33. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.
Zhou YM; Yang JM; Wang B; Xu F; Tong Y; Li DQ
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):656-9. PubMed ID: 18086637
[TBL] [Abstract][Full Text] [Related]
34. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
Ehlken H; Schramm C
Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
[TBL] [Abstract][Full Text] [Related]
35. Assessment of endoscopic aspiration cytology and endoscopic retrograde cholangio-pancreatography in patients with cancer of the hepato-biliary tract. Part II.
Harada H; Sasaki T; Yamamoto N; Tanaka J; Tomiyama Y
Gastroenterol Jpn; 1977; 12(1):59-64. PubMed ID: 863180
[TBL] [Abstract][Full Text] [Related]
36. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
Shetty AS; Fowler KJ; Brunt EM; Agarwal S; Narra VR; Menias CO
Abdom Imaging; 2014 Apr; 39(2):310-22. PubMed ID: 24407728
[TBL] [Abstract][Full Text] [Related]
37. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
38. [Malignant lesions of the extrahepatic biliary system].
Litchinko A; Peloso A; Toso C; Compagnon P
Rev Med Suisse; 2022 Jun; 18(786):1210-1217. PubMed ID: 35703864
[TBL] [Abstract][Full Text] [Related]
39. [Hepatocellular carcinoma and cholangiocarcinoma].
Rauchfuss F; Scheuerlein H; Götz M; Dittmar Y; Voigt R; Heise M; Settmacher U
Chirurg; 2010 Oct; 81(10):941-52; quiz 953. PubMed ID: 20827454
[TBL] [Abstract][Full Text] [Related]
40. Surgical management of cholangiocarcinoma.
Jarnagin WR; Shoup M
Semin Liver Dis; 2004 May; 24(2):189-99. PubMed ID: 15192791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
